
Daiichi Sankyo believes that the claims made in this litigation are without merit, and does not admit liability.”
We don’t believe we did anything wrong and it doesn’t matter much anyway ...
continue reading...
Daiichi Sankyo believes that the claims made in this litigation are without merit, and does not admit liability.”
We don’t believe we did anything wrong and it doesn’t matter much anyway ...
continue reading...
Benicar is Japan-based company Daiichi Sankyo’s bestselling hypertension drug. The U.S. Food and Drug Administration (FDA) approved Benicar in 2002, and since then the drug has been prescribed to over 11 million U.S. patients. But in 2013, the ...
continue reading...
Daiichi Sankyo’s Benicar was approved by the FDA in 2002 to help treat patients with high blood pressure. It quickly became one of ...
continue reading...
Benicar was approved by the U.S. Food and Drug Administration (FDA) in 2002 for use as a blood pressure medication. ...
continue reading...
Sankyo’s most recent nine-month report indicates that the company’s North American revenue increased 6 percent from the previous year but fell by 1.5 percent in terms of ...
continue reading...
A ...
continue reading...